Gastrointestinal drugs

Langman, M.J.S.

doi:10.1016/s0378-6080(79)80042-2

Side Effects of Drugs Annual

1979

DOI: 10.1016/s0378-6080(79)80042-2

|View full text |Cite

Gastrointestinal drugs

M.J.S. Langman¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1993

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Relationship between bisacodyl‐induced urolithiasis and rat urinary bladder tumorigenesis

Toyoda¹,

Imaida²,

Shirai³

et al. 1993

Journal of Toxicology and Environmental Health

View full text Add to dashboard Cite

Dietary supplementation with bisacodyl at concentrations ranging from 1 to 0.3% was found to induce both calculi and epithelial proliferative lesions, including a transitional-cell carcinoma, in the urinary bladder of F344/DuCrj rats. In order to clarify the relationship between the bisacodyl-associated urinary bladder calculi and the development of proliferative lesions in the urinary bladder, male and female rats were administered bisacodyl-diets at concentrations of 0.3, 0.1, and 0.03% for 32 wk. Both sexes of animals treated with bisacodyl suffered from diarrhea throughout the experimental period. Epithelial proliferative lesions and calculus formation were observed only in the urinary bladder of male rats given the 0.3% bisacodyl diet. Proliferative lesions and increases of bromouracil deoxyriboside (BUdR) labeling indices were found only in the urinary bladder epithelium of rats with calculi, the severity of the former correlating with the calculus weight and being most marked in the dome areas, which are susceptible to physical stimulation. These findings indicate a close relationship between the development of proliferative lesions and the existence of calculi in the urinary bladder, and suggest that bisacodyl-induced proliferative lesions are not caused directly by bisacodyl per se but are secondary to calculus formation.

show abstract

Relationship between bisacodyl‐induced urolithiasis and rat urinary bladder tumorigenesis

Toyoda¹,

Imaida²,

Shirai³

et al. 1993

Journal of Toxicology and Environmental Health

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Gastrointestinal drugs

Cited by 1 publication

References 23 publications

Relationship between bisacodyl‐induced urolithiasis and rat urinary bladder tumorigenesis

Relationship between bisacodyl‐induced urolithiasis and rat urinary bladder tumorigenesis

Contact Info

Product

Resources

About